About
Marius is a Counsel in the Global Transactions, Intellectual Property and Information Technology (IP/IT) practice area in our Hamburg office.
He advises national and international clients on carve-outs, intellectual property, IT and commercial law - both by way of general advice and in connection with M&A transactions and outsourcing projects. Clients he regularly instructs include private equity companies, large industrial companies as well as businesses in the information technology and healthcare sectors.
He speaks German and English.
Additional Information
- Advising Merck on the sale of its Surface Solutions Business to Global New Material International Holdings Ltd.
- Advising Barclays on the sale of its German consumer finance business to Austria-based BAWAG Group
- Advising Deutz on the acquisition of a diesel engine business from Rolls-Royce Power Systems
- Advising Näder Holding on the repurchase of 20% of the shares in Ottobock from the Swedish private equity firm EQT
- Advising Röhm on the acquisition of SABIC’s Functional Forms business
- Advising Cinven on its acquisition of MBCC Group’s Admixtures business from Sika
- Advising International Chemical Investors Group (ICIG) on their sale of CordenPharma (leading global CDMO (contract development & manufacturing organization)) to European private equity firm Astorg
- Advising LANXESS on the purchase of the Microbial Control Business of International Flavors & Fragrances (IFF)
- Advising thyssenkrupp on the sale of the mining plant engineering business to FLS Smidth, Denmark, and the complex carve-out of the activities from the Plant Technology division, implemented in parallel to the M&A track
- Advising a European aerospace corporation on development and supply agreements for passenger-to-freighter conversion of aircraft
- Advising a bidder in the auction process for the acquisition of the construction chemicals business of a large international chemicals corporation in the context of a carve-out
- Advising a bidder in the auction process for the acquisition of Lonza's Specialty Ingredients business in a carve-out
- Advising MYR shareholders on the acquisition of MYR by Gilead Sciences for a purchase price of EUR 1.15 bn and further performance-related bonuses
- Advising Novartis on its USD 5.2bn acquisition of the pharmaceutical product Xiidra from Takeda/Shire
- Advising LANXESS on the carve-out and divestiture of its worldwide organic leather chemicals business to TFL Ledertechnik
- Advising Zurich-based gategroup on the acquisition of the European business of Lufthansa’s catering subsidiary LSG Sky Chefs
- Advising Advent International on the acquisition of Evonik's methacrylates business
- Advising Merck on its EUR 3.4bn carve-out und sale of its consumer health business to Procter & Gamble
Marius Scherb
Counsel
Hamburg Office
Hohe Bleichen 7
20354 Hamburg